Last updated: January 14, 2024
Sponsor: Ain Shams University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia
Fast Heart Rate (Tachycardia)
Heart Defect
Treatment
Phenylephrine
Clinical Study ID
NCT06220942
FMASUR338/2023
Ages 18-35 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ASA II pregnant female planned for elective C.S., aged between 18 -35 years old.
Exclusion
Exclusion Criteria:
- Emergency CS, Complicated CS (Severe bleeding, organ injury, uterine atony), ASA III,VI patients with cardiovascular diseases
Study Design
Total Participants: 80
Treatment Group(s): 1
Primary Treatment: Phenylephrine
Phase:
Study Start date:
October 05, 2023
Estimated Completion Date:
May 31, 2024
Study Description
Connect with a study center
maha sadek El Derh
Cairo, Heliopolis 11721
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.